Why is there no agreement on new drug approval for Janssen in the US?

In September, the US Food and Drug Administration approved Jansson for use in children aged 6-17 months.The company has been working on an application for approval in the United Kingdom, which would enable it to be available for use by adults.However, it has been unable to reach an agreement on this because of the United […]

Read more